Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Biomea Fusion stock | $11.74

Learn how to easily invest in Biomea Fusion stock.

Biomea Fusion Inc is a biotechnology business based in the US. Biomea Fusion shares (BMEA) are listed on the NASDAQ and all prices are listed in US Dollars. Biomea Fusion employs 20 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Biomea Fusion

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BMEA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biomea Fusion stock price (NASDAQ: BMEA)

Use our graph to track the performance of BMEA stocks over time.

Biomea Fusion shares at a glance

Information last updated 2021-10-17.
Latest market close$11.74
52-week range$9.72 - $22.22
50-day moving average $11.94
200-day moving average $14.71
Wall St. target price$26.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.23

Buy Biomea Fusion shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biomea Fusion stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biomea Fusion price performance over time

Historical closes compared with the close of $11.74 from 2021-10-19

1 week (2021-10-13) 4.92%
1 month (2021-09-20) 13.43%
3 months (2021-07-20) -13.93%
6 months (2021-04-20) -30.08%
1 year (2020-10-16) N/A
2 years (2019-10-16) N/A
3 years (2018-10-16) N/A
5 years (2016-10-16) N/A

Biomea Fusion financials

Gross profit TTM $0
Return on assets TTM -10.6%
Return on equity TTM -17.49%
Profit margin 0%
Book value $6.97
Market capitalisation $337.3 million

TTM: trailing 12 months

Shorting Biomea Fusion shares

There are currently 1.6 million Biomea Fusion shares held short by investors – that's known as Biomea Fusion's "short interest". This figure is 14% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Biomea Fusion shares can be evaluated.

Biomea Fusion's "short interest ratio" (SIR)

Biomea Fusion's "short interest ratio" (SIR) is the quantity of Biomea Fusion shares currently shorted divided by the average quantity of Biomea Fusion shares traded daily (recently around 78392.966507177). Biomea Fusion's SIR currently stands at 20.9. In other words for every 100,000 Biomea Fusion shares traded daily on the market, roughly 20900 shares are currently held short.

To gain some more context, you can compare Biomea Fusion's short interest ratio against those of similar companies.

However Biomea Fusion's short interest can also be evaluated against the total number of Biomea Fusion shares, or, against the total number of tradable Biomea Fusion shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biomea Fusion's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Biomea Fusion shares in existence, roughly 60 shares are currently held short) or 0.1141% of the tradable shares (for every 100,000 tradable Biomea Fusion shares, roughly 114 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Biomea Fusion.

Find out more about how you can short Biomea Fusion stock.

Biomea Fusion share dividends

We're not expecting Biomea Fusion to pay a dividend over the next 12 months.

Biomea Fusion overview

Biomea Fusion, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of MENIN, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was founded in 2017 and is headquartered in Redwood City, California. .

Frequently asked questions

What percentage of Biomea Fusion is owned by insiders or institutions?
Currently 33.536% of Biomea Fusion shares are held by insiders and 58.679% by institutions.
How many people work for Biomea Fusion?
Latest data suggests 20 work at Biomea Fusion.
When does the fiscal year end for Biomea Fusion?
Biomea Fusion's fiscal year ends in December.
Where is Biomea Fusion based?
Biomea Fusion's address is: Chamberlain Building, Redwood City, CA, United States, 94063
What is Biomea Fusion's ISIN number?
Biomea Fusion's international securities identification number is: US09077A1060

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site